Rockefeller Capital Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,898
Closed -$240K 2054
2023
Q1
$240K Buy
3,898
+3,892
+64,867% +$234K ﹤0.01% 1714
2022
Q4
$0 Hold
6
﹤0.01% 4280
2022
Q3
$0 Sell
6
-200
-97% -$14.9K ﹤0.01% 4468
2022
Q2
$14K Buy
206
+171
+489% +$12.3K ﹤0.01% 2965
2022
Q1
$3K Sell
35
-16
-31% -$1.31K ﹤0.01% 3542
2021
Q4
$4K Buy
51
+29
+132% +$2.48K ﹤0.01% 3387
2021
Q3
$1K Sell
22
-7
-24% -$588 ﹤0.01% 3635
2021
Q2
$2K Sell
29
-1,230
-98% -$119K ﹤0.01% 3284
2021
Q1
$134K Sell
1,259
-624
-33% -$64.7K ﹤0.01% 1485
2020
Q4
$164K Buy
+1,883
New +$133K ﹤0.01% 1261

Other funds holding NARI

Rockefeller Capital Management's NARI Position: Q2 2023 in Review

Rockefeller Capital Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2023, closing a stake of 3,898 shares — an estimated $240K sold.

Rockefeller Capital Management first reported a position in NARI in Q4 2020 and held it in 10 quarters. The position peaked at $240K in Q1 2023. 250 funds tracked by Wall St. Rank hold NARI as of Q2 2023.

  • Rockefeller Capital Management reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 3,898 Inari Medical, Inc. Common Stock shares in Q2 2023, an estimated $240K.
  • Rockefeller Capital Management first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Rockefeller Capital Management's Inari Medical, Inc. Common Stock position peaked at $240K in Q1 2023.
  • 250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2023.

Based on Rockefeller Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.